A meta-analysis of deep hypothermic circulatory arrest alone versus with adjunctive selective antegrade cerebral

David H Tian1, Benjamin Wan, Paul G Bannon

  • 1Collaborative Research (CORE) Group, Sydney, Australia;

Insights

Deep hypothermic circulatory arrest with selective antegrade cerebral perfusion (DHCA + SACP) improves survival outcomes in aortic arch surgery compared to DHCA alone. This meta-analysis found no significant neurological differences between the neuroprotection strategies.

Area of Science:

  • Cardiovascular Surgery
  • Neurosurgery
  • Medical Technology

Background:

  • Deep hypothermic circulatory arrest (DHCA) is crucial for neuroprotection during aortic arch surgery by reducing cerebral metabolic activity.
  • Selective antegrade cerebral perfusion (SACP) is an adjunct to DHCA for extended procedures, but carries risks of embolism and perfusion abnormalities.
  • The optimal neuroprotection strategy for aortic arch surgery remains a subject of investigation.

Purpose of the Study:

  • To compare postoperative outcomes between DHCA alone and DHCA with SACP (DHCA + SACP) in aortic arch surgery.
  • To evaluate the efficacy of these neuroprotection strategies in reducing neurological injury and improving survival.
  • To synthesize evidence from existing comparative studies through a meta-analysis.

Main Methods:

  • A systematic literature search was conducted across six databases up to January 2013.
  • Two independent reviewers identified and selected comparative studies of DHCA alone versus DHCA + SACP.
  • Data from nine identified studies involving 648 patients (DHCA alone) and 370 patients (DHCA + SACP) were extracted and meta-analyzed.

Main Results:

  • No significant differences were observed in temporary or permanent neurological outcomes between the two groups.
  • DHCA + SACP demonstrated significantly better survival outcomes (P=0.008) compared to DHCA alone, despite longer cardiopulmonary bypass times.
  • Analysis of other systemic outcomes was precluded due to inconsistent reporting in the included studies.

Conclusions:

  • DHCA + SACP is associated with superior mortality outcomes in aortic arch surgery.
  • While neurological outcomes were similar, the survival benefit suggests DHCA + SACP may be a preferred neuroprotection strategy.
  • Further research with consistent reporting of systemic outcomes is warranted.
Abstract